Replicating LSD microdose

Comment · Sat, August 22, 2020 · 58 pts

We are working on some things that actually might. I can't discuss them yet, as we are still in the patent process. However, we have discovered some interesting natural extracts that can hit receptors in a similar fashio

Comment · Sat, August 22, 2020 · 29 pts

I've been personally taking one of them for about a year. I can tell you it is pretty damn cool! The fact that we can get this effect out of a natural extract is bonkers. When I shut Ceretropic down, I feared we would no

Comment · Sun, August 23, 2020 · 17 pts

I am hoping soon. Perhaps before the end of the year.

Comment · Sun, August 23, 2020 · 8 pts

BPC-157 and TB-500 helped me heal from a batched shoulder surgery and nerve damage caused by the surgeons. It's helped my wife and mom recover from similar injuries as well. It's insane how well they work!

Comment · Sun, August 23, 2020 · 7 pts

I am hoping so! We only have an R&D test batch at the moment. That's what I have been using. We just started the process of doing a scale up of the process to prove it works before we do a full blown production batch.

Comment · Sun, August 23, 2020 · 10 pts

Correct. It hits the 5-HT2A receptors. Taking a normal dose feels very much like a microdose of 4-ACO-DMT. I have not yet tried a higher dose to see what happens, but that is in my plans soon. Gotta be the guinea pig! We

Comment · Mon, August 24, 2020 · 5 pts

No, we don't sell things till we are done with our internal R&D and beta testing. We might offer a program for customers to be a part of beta testing in the future, but right now we do it all internally.

Comment · Thu, August 27, 2020 · 3 pts

I use ours.

Comment · Thu, August 27, 2020 · 3 pts

I found cissus to help as well. I still don't know what compound in cissus is doing the bulk of it, though.

Comment · Thu, August 27, 2020 · 8 pts

We are not launching BPC and TB. I am the founder of Ceretropic. I shut down US operations over 2 years ago, though. We still support our Latin American distributors, and still make peptides for outside of the US. So I j

Comment · Tue, September 1, 2020 · 2 pts

For external beta testing? Yes, we will have eligibility criteria.

Comment · Tue, September 1, 2020 · 5 pts

No, it does not interact with 5-HT2B.

Comment · Thu, September 3, 2020 · 3 pts

Ohh jesus, 50?!? LOL

Comment · Fri, September 4, 2020 · 3 pts

Hmmm, sub-Q injection that made you look younger. That looks like it was PF-06946860. https://clinicaltrials.gov/ct2/show/NCT03599063 They went from 0.1mg to 100mg. I wonder what dose you got? LOL. No idea what the com

Comment · Fri, September 4, 2020 · 2 pts

Not personally, no.

Comment · Fri, September 4, 2020 · 2 pts

Unfortunately not. There are none.

Comment · Sat, September 5, 2020 · 3 pts

It would be difficult, as pharma companies maintain a tight ship. It took us forever to even know what the structure of NRX-1074 was. There were years of speculation first. I am not sure we will know the structure of PF-

Comment · Sat, September 19, 2020 · 5 pts

Yes, likely so. I have noticed that effect in my trials, but it is nothing like taking 4-ACO-DMT daily. I have taken this extract daily for months on end without issue. Sure, it's not as strong as day one, but not burnin

Comment · Sun, November 29, 2020 · 3 pts

Getting closer. I am hoping Jan/Feb time frame.

Comment · Wed, December 16, 2020 · 10 pts

Pilot batch should be here soon. I think right after the first of the year.

Comment · Sat, January 9, 2021 · 5 pts

I'll have to check with them on Monday. I have not heard an update yet.

Comment · Wed, January 20, 2021 · 2 pts

We'll post about it here on /r/NootropicsDepot when it is, send an email to our subscribers, and post about it on our other social medias as well.

Comment · Thu, January 21, 2021 · 6 pts

We will give it a name that we have developed for it, so look out for a new extract with a trademarked name from us. I will make a big deal out of it here on Reddit, anyways. You will certainly know when it is released.

Comment · Sat, January 30, 2021 · 5 pts

Yes, absolutely! In fact, we already are!

Comment · Wed, February 3, 2021 · 5 pts

Definitely longer than that. This is our scaled up pilot batch. It's not a full batch, and we need to do beta testing on the dose now that it is more potent.

Comment · Thu, February 4, 2021 · 1 pts

Yeah, and maybe some external beta testing.

Comment · Sat, February 6, 2021 · 1 pts

We have not setup the program yet, but we are considering it.

Comment · Sat, February 6, 2021 · 2 pts

It was delayed a few more days, unfortunately.

Comment · Sun, February 7, 2021 · 1 pts

>A monoclonal antibody directed against the human growth differentiation factor 15 (GDF15; MIC-1), with potential anti-cachexia activity. Upon administration, ponsegromab targets and binds to GDF15, thereby preventing th

Comment · Sun, February 7, 2021 · 2 pts

Still working on it. Slight delay popped up. Will be a little bit still.

Comment · Sun, February 7, 2021 · 4 pts

Thank you! I really do appreciate it. It's nice knowing what I am doing has support behind it!

Comment · Tue, February 16, 2021 · 2 pts

Probably longer. We ran into a snag.

Comment · Wed, February 17, 2021 · 3 pts

The pilot batch scale up was supposed to result in 10% of a specific active, and initial tests showed it hit like 12%. However, it only eventually hit 7%. That's fine, since the first R&D batches were only 4-5%. However,